Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?
Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?
复制标题
DOI:
10.1152/ajpendo.00137.2010
复制
发表时间:
2010-07-01
影响因子:
5.1
通讯作者:
Knop, Filip K.
中科院分区:
文献类型:
--
作者:
Knop, Filip K.
Knop FK. Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes? Am J Physiol Endocrinol Metab 299: E10-E13, 2010. First published April 27, 2010; doi:10.1152/ajpendo.00137.2010.-During the last decades it has become clear that bile acids not only act as simple fat solubilizers, but additionally represent complex hormonal metabolic integrators. Bile acids activate both nuclear receptors (controlling transcription of genes involved in for example bile acid, cholesterol, and glucose metabolism) and the cell surface G protein-coupled receptor TGR5 (modulating energy expenditure in brown fat and muscle cells). It has been shown that TGR5 is expressed in enteroendocrine L cells, which secrete the potent glucose-lowering incretin hormone glucagon-like peptide-1 (GLP-1). Recently it was shown that bile acid-induced activation of TGR5 results in intestinal secretion of GLP-1 and that enhanced TGR5 signaling improves postprandial glucose tolerance in diet-induced obese mice. This Perspectives article presents these novel findings in the context of prior studies on nutrient-induced GLP-1 secretion and outlines the potential implications of bile acid-induced GLP-1 secretion in physiological, pathophysiological, and pharmacological perspectives.